Gómez-Echarte, N., Carrasco-Leon, A., Maiques-Diaz, A., Barrena, N., Miranda, E., Garate, L., Amundarain, A., Martín-Uriz, P. S., Charalampopoulou, S., Valcárcel, L. V., Ariceta, B., Rodriguez-Marquez, P., Rodriguez-Madoz, J. R., Ishiguro, K., Planes, F. J., Rodriguez-Otero, P., Mitsiades, C. S., Martín-Subero, J. I., José-Enériz, E. S., Prosper, F., Agirre, X. (2026). IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma. Blood. https://doi.org/10.1182/blood.2025029422